Davidoff AM - Search Results

1

Ex vivo activation of CD56(+) immune cells that eradicate neuroblastoma.

Rujkijyanont P, Chan WK, Eldridge PW, Lockey T, Holladay M, Rooney B, Davidoff AM, Leung W, Vong Q. Rujkijyanont P, et al. Among authors: davidoff am. Cancer Res. 2013 Apr 15;73(8):2608-18. doi: 10.1158/0008-5472.CAN-12-3322. Epub 2013 Feb 25. Cancer Res. 2013. PMID: 23440424

2

Enhanced neuroblastoma transduction for an improved antitumor vaccine.

Davidoff AM, Stevenson SC, McClelland A, Shochat SJ, Vanin EF. Davidoff AM, et al. J Surg Res. 1999 May 15;83(2):95-9. doi: 10.1006/jsre.1999.5572. J Surg Res. 1999. PMID: 10329101

3

Neuroblastoma regression and immunity induced by transgenic expression of interleukin-12.

Davidoff AM, Kimbrough SA, Ng CY, Shochat SJ, Vanin EF. Davidoff AM, et al. J Pediatr Surg. 1999 May;34(5):902-6; discussion 906-7. doi: 10.1016/s0022-3468(99)90395-0. J Pediatr Surg. 1999. PMID: 10359203

4

rAAV-mediated long-term liver-generated expression of an angiogenesis inhibitor can restrict renal tumor growth in mice.

Davidoff AM, Nathwani AC, Spurbeck WW, Ng CY, Zhou J, Vanin EF. Davidoff AM, et al. Cancer Res. 2002 Jun 1;62(11):3077-83. Cancer Res. 2002. PMID: 12036917

5

Retroviral vector-producer cell-mediated in vivo gene transfer of TIMP-3 restricts angiogenesis and neuroblastoma growth in mice.

Spurbeck WW, Ng CY, Vanin EF, Davidoff AM. Spurbeck WW, et al. Among authors: davidoff am. Cancer Gene Ther. 2003 Mar;10(3):161-7. doi: 10.1038/sj.cgt.7700577. Cancer Gene Ther. 2003. PMID: 12637936

6

Interferon-mediated anti-angiogenic therapy for neuroblastoma.

Streck CJ, Ng CY, Zhang Y, Zhou J, Nathwani AC, Davidoff AM. Streck CJ, et al. Among authors: davidoff am. Cancer Lett. 2005 Oct 18;228(1-2):163-70. doi: 10.1016/j.canlet.2004.11.063. Cancer Lett. 2005. PMID: 15927362 Review.

7

Adeno-associated virus vector-mediated systemic delivery of IFN-beta combined with low-dose cyclophosphamide affects tumor regression in murine neuroblastoma models.

Streck CJ, Dickson PV, Ng CY, Zhou J, Gray JT, Nathwani AC, Davidoff AM. Streck CJ, et al. Among authors: davidoff am. Clin Cancer Res. 2005 Aug 15;11(16):6020-9. doi: 10.1158/1078-0432.CCR-05-0502. Clin Cancer Res. 2005. PMID: 16115947

8

The impact of early resection of primary neuroblastoma on the survival of children older than 1 year of age with stage 4 disease: the St. Jude Children's Research Hospital Experience.

McGregor LM, Rao BN, Davidoff AM, Billups CA, Hongeng S, Santana VM, Hill DA, Fuller C, Furman WL. McGregor LM, et al. Among authors: davidoff am. Cancer. 2005 Dec 15;104(12):2837-46. doi: 10.1002/cncr.21566. Cancer. 2005. PMID: 16288490 Free article.

9

Efficacy of zoledronate against neuroblastoma.

Dickson PV, Hamner JB, Cauthen LA, Ng CY, McCarville MB, Davidoff AM. Dickson PV, et al. Among authors: davidoff am. Surgery. 2006 Aug;140(2):227-35. doi: 10.1016/j.surg.2006.02.004. Surgery. 2006. PMID: 16904974

10

Bevacizumab-induced transient remodeling of the vasculature in neuroblastoma xenografts results in improved delivery and efficacy of systemically administered chemotherapy.

Dickson PV, Hamner JB, Sims TL, Fraga CH, Ng CY, Rajasekeran S, Hagedorn NL, McCarville MB, Stewart CF, Davidoff AM. Dickson PV, et al. Among authors: davidoff am. Clin Cancer Res. 2007 Jul 1;13(13):3942-50. doi: 10.1158/1078-0432.CCR-07-0278. Clin Cancer Res. 2007. PMID: 17606728

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

372 results

Search Page